A Study of DT2216 in Relapsed/Refractory Malignancies

Clinical trial NCT04886622 · COMPLETED

Trial details

NCT number: NCT04886622
Sponsor: Dialectic Therapeutics, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Hematologic Malignancy

Start date: 2021-08-25
Primary completion: 2024-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.